Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancer
Epithelial-mesenchymal transition (EMT) is essentially a way for epithelial cells to loosen their structure and take on a more mobile, survival-driven identity. In ovarian cancer, this shift may be one of the reasons the disease spreads so readily and comes back despite intensive treatment. A mix of transcription factors Snail, Slug, Twist, the ZEB family and signals from pathways like TGF-β, Wnt, Notch, and PI3K/Akt seem to push cells in this direction. MicroRNAs add small but critical nudges that can either hold the process back or move it further along. But EMT rarely happens as a one-way switch. Ovarian cancer cells often sit somewhere between the two ends of the spectrum, switching identities when needed. This fluid behavior, sometimes called epithelial-mesenchymal plasticity, might help explain why tumors become more diverse, more stem-like, and harder to eliminate. Conditions around the tumor also play a role. Hypoxic pockets, a stiff extracellular matrix, and inflammatory signals not only surround the cancer but may also encourage EMT and help maintain drug-tolerant cells. It's still unclear which of these influences is most decisive, and that uncertainty leaves room for debate. Targeting EMT directly is an appealing idea, and a few strategies are being tested. Whether reversing EMT or stabilizing epithelial features will make standard therapies more effective is not yet settled, but the possibility is driving new interest in combination approaches for ovarian cancer.